Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer

Artículo

Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer

Karthik Ambalavana et al · Thieme Medical and Scientific Publishers Pvt. Ltd

Acceso abierto disponible

Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Autor / responsable

Karthik Ambalavana et al

Editorial

Thieme Medical and Scientific Publishers Pvt. Ltd

ISSN

0971-5851

ISSN

0971-5851

Idioma

eng

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto disponible

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.

Abrir recurso

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, K. A. E. (s. f.). Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer. https://doi.org/10.1055/s-0046-1820441

MLA

al, Karthik Ambalavana et. "Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer.". https://doi.org/10.1055/s-0046-1820441.

Chicago

al, Karthik Ambalavana et. s. f. "Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer.". https://doi.org/10.1055/s-0046-1820441.

Harvard

al, K. A. E. s. f, Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer, Thieme Medical and Scientific Publishers Pvt. Ltd, available at: https://doi.org/10.1055/s-0046-1820441 [Accessed 29 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

RIS BibTeX

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título: Assessment of Pathological Complete Response Rates with the Addition of Carboplatin to the Sequential Taxane–Anthracycline Chemotherapy in Patients with Nonmetastatic Triple-Negative Breast Cancer

Autor / colaboradores: Karthik Ambalavana et al

Editorial: Thieme Medical and Scientific Publishers Pvt. Ltd

ISSN: 0971-5851

ISSN: 0971-5851

Idioma: eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

triple-negative breast cancer; neoadjuvant chemotherapy; pathological complete response; carboplatin